Sarepta Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

Sarepta Therapeutics M&A Summary

Sarepta Therapeutics has acquired 1 company, including 1 in the last 5 years.

Sarepta Therapeutics’ largest acquisition to date was in 2019, when it acquired Myonexus Therapeutics for $165M. Sarepta Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Sarepta Therapeutics Business Overview

Where is Sarepta Therapeutics headquartered?

Sarepta Therapeutics is headquartered in Cambridge, Massachusetts.

What is Sarepta Therapeutics’ revenue?

Sarepta Therapeutics disclosed revenue of 1,243M USD for 2023 and 933M USD for 2022.

How many employees does Sarepta Therapeutics have?

Sarepta Therapeutics has 1,314 employees.

What sector is Sarepta Therapeutics in?

Sarepta Therapeutics is a life science company.

When was Sarepta Therapeutics founded?

Sarepta Therapeutics was founded in 1980.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Sarepta Therapeutics

Sarepta Therapeutics, Inc.

215 First Street, Suite 415,
Cambridge, Massachusetts 02142
United States,
(617) 274-4000
www.sarepta.com

Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on discovering and developing unique RNA-targeted therapeutics for treating rare neuromuscular diseases. Sarepta Therapeutics was founded in 1980 and is based in Cambridge, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $165M $165M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Myonexus Therapeutics 2019-02-27 165M USD Add-on Acquisition
New Albany, Ohio · www.myonexustx.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Myonexus Therapeutics 2019-02-27 Creapharm’s Clinical & Commercial Packaging and Bioservices Business 2024-03-15 2
New Albany, Ohio · www.myonexustx.com Reims, France

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 165M (100%) - -
Total 1 $165M - -

By Geo

State/Country Buy Value Sell Value
United States 1 165M - -
  Ohio 1 165M - -
Total 1 $165M - -

Deal Values

buy # Total
$100M to $1B 1 $165M
TOTAL $165M
Largest Myonexus Therapeutics
$165M (2019-02-27)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.